Testing rare variants for hypertension using family-based tests with different weighting schemes

Area of Science:

• Genetics
• Statistical Genetics
• Bioinformatics

Background:

• Next-generation sequencing enables direct testing of rare genetic variants.
• Existing methods for common variants may be suboptimal for rare variants due to allelic heterogeneity and rarity.
• Population-based and family-based methods for rare variant association studies are emerging.

Purpose of the Study:

• To propose novel weighting schemes for the family-based rare variants test (FBAT-v).
• To enhance the power of rare variant association testing for both rare and common variants across the genome.

Main Methods:

• Developed four distinct weighting schemes for the family-based rare variants test (FBAT-v).
• Applied FBAT-v with proposed weighting schemes to Genetic Analysis Workshop 19 family data.
• Compared the performance of the enhanced FBAT-v against existing methods.

Main Results:

• The proposed weighting schemes comparatively enhanced the power of FBAT-v in most circumstances.
• Family-based methods demonstrated advantages over population-based methods, including reduced bias from population substructure.
• The effectiveness of FBAT-v was validated on real genetic data.

Conclusions:

• The developed weighting schemes offer a significant improvement for family-based rare variant association studies.
• FBAT-v with optimized weighting is a powerful tool for identifying genetic associations involving rare and common variants.
• This approach holds promise for advancing genetic research in complex diseases.